IL10 and systemic sclerosis: Considering that CD163 expression on monocytes are modulated by pro-anti-inflammatory mediators such as IL-10 [16,31], an increased number of CD163+ cells in CD14+PBMCs in our study may be interpreted as the direct result of increased serum IL-10 in SSc patients [17-19].